BIOMAT Database Logo BIOMAT Database Logo

Technetium-99m-pyrophosphate bone scans in hyperparathyroidism. 1977

T Wiegmann, and L Rosenthall, and M Kaye

Most patients with primary hyperparathyroidism have normal 5-hr bone-to-soft-tissue ratios for 99MTc-pyrophosphate. In contrast, all five patients with advanced secondary hyperparathyroidism in this study showed significant (p less than 0.001) increases of bone uptake. In the early period after parathyroidectomy, there was no quantitative or qualitative change in uptake. A limited decrease of bone uptake was observed only after prolonged periods of observation. In itself, parathyroid activity seems to have little direct influence on bone uptake of 99MTc-pyrophosphate.

UI MeSH Term Description Entries
D006961 Hyperparathyroidism A condition of abnormally elevated output of PARATHYROID HORMONE (or PTH) triggering responses that increase blood CALCIUM. It is characterized by HYPERCALCEMIA and BONE RESORPTION, eventually leading to bone diseases. PRIMARY HYPERPARATHYROIDISM is caused by parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. SECONDARY HYPERPARATHYROIDISM is increased PTH secretion in response to HYPOCALCEMIA, usually caused by chronic KIDNEY DISEASES.
D006962 Hyperparathyroidism, Secondary Abnormally elevated PARATHYROID HORMONE secretion as a response to HYPOCALCEMIA. It is caused by chronic KIDNEY FAILURE or other abnormalities in the controls of bone and mineral metabolism, leading to various BONE DISEASES, such as RENAL OSTEODYSTROPHY. Secondary Hyperparathyroidism,Hyperparathyroidisms, Secondary,Secondary Hyperparathyroidisms
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010281 Parathyroid Hormone A polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular calcium by promoting the release of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the renal tubular reabsorption of calcium, and increases the renal excretion of phosphates. Natpara,PTH (1-84),PTH(1-34),Parathormone,Parathyrin,Parathyroid Hormone (1-34),Parathyroid Hormone (1-84),Parathyroid Hormone Peptide (1-34),Hormone, Parathyroid
D011756 Diphosphates Inorganic salts of phosphoric acid that contain two phosphate groups. Diphosphate,Pyrophosphate Analog,Pyrophosphates,Pyrophosphate Analogs,Analog, Pyrophosphate
D011877 Radionuclide Imaging The production of an image obtained by cameras that detect the radioactive emissions of an injected radionuclide as it has distributed differentially throughout tissues in the body. The image obtained from a moving detector is called a scan, while the image obtained from a stationary camera device is called a scintiphotograph. Gamma Camera Imaging,Radioisotope Scanning,Scanning, Radioisotope,Scintigraphy,Scintiphotography,Imaging, Gamma Camera,Imaging, Radionuclide
D001842 Bone and Bones A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX. Bone Tissue,Bone and Bone,Bone,Bones,Bones and Bone,Bones and Bone Tissue,Bony Apophyses,Bony Apophysis,Condyle,Apophyses, Bony,Apophysis, Bony,Bone Tissues,Condyles,Tissue, Bone,Tissues, Bone
D001862 Bone Resorption Bone loss due to osteoclastic activity. Bone Loss, Osteoclastic,Osteoclastic Bone Loss,Bone Losses, Osteoclastic,Bone Resorptions,Loss, Osteoclastic Bone,Losses, Osteoclastic Bone,Osteoclastic Bone Losses,Resorption, Bone,Resorptions, Bone
D005260 Female Females

Related Publications

T Wiegmann, and L Rosenthall, and M Kaye
Re: Technetium-99m-pyrophosphate bone scans in hyperparathyroidism.
January 1980, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
T Wiegmann, and L Rosenthall, and M Kaye
Technetium-99m-pyrophosphate scintigraphy of knee joints in hyperparathyroidism.
January 1977, Lancet (London, England),
T Wiegmann, and L Rosenthall, and M Kaye
99m Technetium-pyrophosphate scintiphotography in bone sarcoidosis.
December 1976, The Journal of rheumatology,
T Wiegmann, and L Rosenthall, and M Kaye
The effect of age on the quality of bone scans using technetium-99m pyrophosphate.
June 1981, Radiology,
T Wiegmann, and L Rosenthall, and M Kaye
Technetium-99m pyrophosphate uptake.
July 1978, Circulation,
T Wiegmann, and L Rosenthall, and M Kaye
[Diagnostic possibilities of bone scintigraphy using Technetium 99m pyrophosphate].
January 1976, La Chirurgia degli organi di movimento,
T Wiegmann, and L Rosenthall, and M Kaye
Technetium-99m-pyrophosphate kinetics and imaging in metabolic bone disease.
January 1975, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
T Wiegmann, and L Rosenthall, and M Kaye
The distal femoral defect: technetium-99m pyrophosphate bone scan results.
June 1982, Journal of the Canadian Association of Radiologists,
T Wiegmann, and L Rosenthall, and M Kaye
Technetium-99m sestamibi scintigraphy and bone densitometry in primary hyperparathyroidism.
January 1999, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,
T Wiegmann, and L Rosenthall, and M Kaye
Utility of technetium Tc 99m pyrophosphate bone scanning in cardiac amyloidosis.
June 1987, Archives of internal medicine,
Copied contents to your clipboard!